| Mary Helen BARCELLOS-HOFF Department of Radiation Oncology, New York University Langone School of Medicine (USA) Leon BIGNOLD Institute of Medical & Veterinary Science, University of Adelaide (Australia) Mariano BIZZARRI Department of Experimental Medicine and Pathology, University “La Sapienza” - Rome (ITA) Guiseppe CARRUBA Department of Oncology, University of Palermo/Sicily (ITA) Harald zurHAUSEN Deutsches Krebsforschungszentrum, Heidelberg (Germany) Markus HORNEBER Abteilung Biologische Krebstherapie, Klinikum Nürnberg/Nord (Germany) Martin LACKMANN Department of Biochemistry & Molecular Biology, Monash University, Victoria (Australia) Yuri LAZEBNIK Cold Spring Harbor Laboratory, New York (USA) Marc MESNIL Institut de Physiologie et Biologie Cellulaires (IPBC), Equipe "Physiopathologie de la Communication et de la Différenciation Cellulaires", Université de Poitiers (France) Marty SERENO Department of Neurolimaging, Birbeck-UCL Centre for Neurolimaging, London (UK) Ana SOTO Department of Anatomy and Cell Biology Tufts University School of Medicine, Boston (USA) Freda STEVENSON Molecular Immunology Group, Cancer Sciences Division, School of Medicine, University of Southhampton (UK) Tadatsugu TANIGUCHI Department of Immunology, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, University of Tokyo (Japan) James E. TROSKO Department of Pediatrics and Human Development, Center for Integrative Toxicology, Michigan State University (USA) Karin de VISSER Department of Molecular Biology. The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam (NL) |